283 results match your criteria: "Halothane Hepatotoxicity"

Article Synopsis
  • Halothane, an anesthetic, can lead to liver damage due to its metabolism into harmful metabolites, specifically CDE and CTE, through the action of cytochrome P450 enzymes.
  • The study aimed to identify which specific P450 isoforms are involved in this metabolic process, finding that P450 2A6 and P450 3A4 play major roles in forming CDE and CTE.
  • Correlation analyses indicated that higher activities of P450 2A6 and 3A4 in human livers are significantly linked to increased production of these metabolites, which suggests potential pathways for targeted inhibition to reduce hepatotoxicity.
View Article and Find Full Text PDF

Drug associated hepatic reactions in New Zealand: 21 years experience.

N Z Med J

August 1996

Centre for Adverse Reactions Monitoring, National Toxicology Group, University of Otago Medical School, Dunedin.

Aims: To review spontaneous reports of drug-associated adverse hepatic reactions.

Methods: Reports of drug-associated adverse hepatic reactions received by the New Zealand Centre for Adverse Reactions Monitoring over the 21 year period January 1974 to December 1994 were reviewed. Subdivision into three 7 year periods was undertaken to compare patterns.

View Article and Find Full Text PDF

Purpose: The aim of this study was to investigate the relation between halothane hepatotoxicity and hepatic free radical metabolism and to establish a possible protective role of vitamin E against halothane hepatotoxicity.

Methods: Twenty-eight guinea pigs were used in the experiments. Halothane (1.

View Article and Find Full Text PDF

Halothane-induced liver injury in guinea-pigs: importance of cytochrome P450 enzyme activity and hepatic blood flow.

J Gastroenterol Hepatol

June 1996

Storr Liver Unit, Department of Medicine, University of Sydney, Westmead Hospital, New South Wales, Australia.

The basis for susceptibility to halothane-induced liver necrosis in guinea-pigs was examined. In hepatic microsomes, the following were similar in susceptible and resistant animals: total cytochrome (CYP) P450 (P450), phenobarbital-inducible pathways of mixed function oxidation (androstenedione 6 beta- and 16 beta-hydroxylase activities) and the CyP2E1-catalysed pathway of N-nitrosodimethylamine N-demethylase activity. Similarly, immunohistochemical staining of CYP2E1 protein was equivalent in livers from susceptible and resistant guinea-pigs.

View Article and Find Full Text PDF

The chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) is a structural analog of halothane. Both are oxidatively metabolized by CYP2EI, producing a reactive trifluoroacyl acid chloride intermediate and have been shown to cause acute liver necrosis in the guinea pig. With halothane, liver injury has been associated with the degree of reactive intermediate binding to hepatic protein.

View Article and Find Full Text PDF

Exposure of human individuals to halothane causes, in about 20% of all cases, a mild transient form of hepatotoxicity. A small subset of exposed individuals, however, develops a potentially severe and life-threatening form of hepatic damage, coined halothane hepatitis. Halothane hepatitis is thought to have an immunological basis.

View Article and Find Full Text PDF

Novel mechanisms in chemically induced hepatotoxicity.

FASEB J

December 1994

Division of Pharmacology, College of Pharmacy and Health Sciences, Northeast Louisiana University, Monroe 71209.

This review focuses on cellular events that modulate hepatotoxicity subsequent to initial liver insult. Cellular events that determine the nature and extent of hepatotoxic injury and the ultimate outcome of that injury are also discussed. The roles of cell types other than hepatocytes, hepatocyte organelle-specific processes, and regeneration in progression or recovery from liver injury are emphasized.

View Article and Find Full Text PDF

Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane.

Biochem Pharmacol

August 1994

INSERM U 49, Unité de Recherches Hépatologiques, Hôpital de Pontchaillou, Rennes, France.

Article Synopsis
  • The study investigates how the anaesthetic halothane is metabolized in the liver, producing a reactive compound called trifluoroacetyl (TFA) halide, which can bind to liver proteins.
  • These TFA-modified proteins can trigger immune responses and are linked to halothane hepatitis in humans.
  • The research demonstrates that primary human hepatocyte cultures can effectively model this process, showing the formation of TFA-antigens and suggesting a valuable tool for studying halothane-related liver damage.
View Article and Find Full Text PDF

Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane.

Toxicol Pathol

February 1995

Toxic Hazards Division, Armstrong Laboratory, Wright-Patterson Air Force Base, Ohio 45433-7400.

Groups of 10 male Hartley guinea pigs were exposed to 3.0, 2.0, 1.

View Article and Find Full Text PDF

Mechanistic insights aid the search for CFC substitutes: risk assessment of HCFC-123 as an example.

Risk Anal

June 1994

U.S. Environmental Protection Agency, Environmental Criteria and Assessment Office (MD-52), Research Triangle Park, North Carolina 27711.

Article Synopsis
  • - An international agreement, the 1987 Montreal Protocol and the 1990 Clean Air Act Amendments, was established to reduce and phase out chlorofluorocarbons (CFCs) and halons due to their harmful effects on the ozone layer and the environment.
  • - The search for safe replacements for CFCs and halons is crucial, prompting the development of toxicity testing and health risk assessment programs to evaluate potential alternatives.
  • - The text discusses an innovative health risk assessment method using PBPK modeling for the replacement chemical HCFC-123, which highlights how data from similar compounds (like halothane) can improve risk evaluations and reduce reliance on animal testing.
View Article and Find Full Text PDF

[Hepatotoxicity of halogenated inhalational anesthetics studied in rats hepatocytes].

Masui

April 1994

Department of Anesthesiology & Critical Care Medicine, Kagoshima University, School of Medicine.

Effects of 2% halothane, 1.5% sevoflurane, 1.5% enflurane, and 1.

View Article and Find Full Text PDF
Article Synopsis
  • * In 1991, preliminary exposure limits for isoflurane, enflurane, and nitrous oxide were set in Hamburg and Schleswig-Holstein.
  • * A study of 20 hospitals in Niedersachsen revealed that anesthetic gas concentrations often exceeded safe limits due to poor ventilation and equipment failures, indicating a need for improved air quality management in operating rooms.
View Article and Find Full Text PDF

Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis.

J Hepatol

March 1994

Unité de Recherche de Physiopathologie Hépatique (INSERM U24), Hôpital Beaujon, Clichy, France.

Possible associations between particular human leucocyte antigen molecules and immunoallergic hepatitis have been suggested previously (HLA-A11 in halothane hepatitis, HLA-DR6 and DR2 in nitrofurantoin hepatitis, HLA-B8 in clometacin hepatitis). In this study the HLA haplotype was determined in 71 patients with idiosyncratic hepatitis due to different drugs. The prevalence of HLA-A11 was twice as high in the 71 patients in the study (23%) as in controls (12%), but p-values were not significant when corrections were made for the large number of comparisons (n = 39).

View Article and Find Full Text PDF

Non-A, non-B fulminant hepatitis is also non-E and non-C.

Am J Gastroenterol

January 1994

Mayo Clinic, Division of Gastroenterology, Rochester, Minnesota.

Objectives: to define the roles of the hepatitis C and E viruses (HCV and HEV) in non-A, non-B (NANB) fulminant hepatitis.

Methods: we utilized the polymerase chain reaction to amplify HCV and HEV RNA sequences and assays to detect antibodies to HCV and HEV in the acute phase sera of eight presumed viral NANB and seven nonviral NANB fulminant hepatic failure (FHF) patients.

Results: none of the 15 patients had detectable HCV or HEV RNA or elevated HCV and IgM-HEV antibody titers in their acute phase sera.

View Article and Find Full Text PDF

Drug-induced hepatic disorders. Incidence, management and avoidance.

Drug Saf

December 1993

Medical Department P, Bispebjerg Hospital, Copenhagen, Denmark.

Article Synopsis
  • Drug-induced liver injury is linked to over 800 drugs and accounts for 2-3% of hospitalizations due to adverse drug reactions, with a serious prognosis for affected patients.
  • Symptoms of drug hepatotoxicity can vary widely and mimic many liver diseases, making a thorough drug history and ruling out other causes essential for diagnosis.
  • Treatment involves stopping the offending drug, using acetylcysteine for paracetamol toxicity, and considering liver transplantation in severe cases, while caution is advised for certain drugs in patients with existing liver issues, especially alcohol users.
View Article and Find Full Text PDF

Background: In hypoxic rats, halothane causes hepatotoxicity at oxygen levels that would cause minimal hepatotoxicity in the absence of halothane. Using a model that excludes systemic and extrahepatic effects of halothane, the authors tested the hypothesis that halothane hepatotoxicity in the whole-rat model is caused by a direct hepatotoxic effect of halothane, which is mediated by halothane-derived free radicals.

Methods: Rat hepatocyte monolayer cultures were exposed to defined gas phases for 2 h.

View Article and Find Full Text PDF

Isoflurane, a halogenated volatile anesthetic, has not been associated with a distinct hepatic injury syndrome, as has halothane. Previous cases of suspected isoflurane-induced hepatotoxicity have been reported but questioned. We report the case of a patient without previous liver disease who developed repeated episodes of hepatitis after repeated exposures to isoflurane.

View Article and Find Full Text PDF

[Halothane hepatitis].

Orv Hetil

August 1993

Semmelweis Orvostudományi Egyetem, II. sz. Belgyógyászati Klinika, Budapest.

The greatest disadvantage of the halothane, widely used in the anaesthesiology is its ability to cause liver damage. After halothane anaesthesia mild liver enzyme elevation in the one fifth of the patients was detected. The incidence of fatal halothane hepatitis is rare.

View Article and Find Full Text PDF

The involvement of free radical reactions in the pathogenesis of liver injury has been investigated for many years in a few defined experimental systems using carbon tetrachloride, excess iron or ethanol as prooxidant agents. More recently, the hepatotoxicity of several other free radical-generating compounds has been characterised mainly in the rat hepatocyte model. In particular, the mechanisms by which drugs like paracetamol, halothane, paraquat or conditions such as ischemia-reperfusion exert their damaging activity to the liver have mostly been clarified.

View Article and Find Full Text PDF

Halothane-induced hepatotoxicity in a Saudi male.

Ann Saudi Med

May 1993

Assistant Professor of Medicine, Consultant Pulmonologist and Consultant-in-Charge of MICU, Professor of Medicine and Consultant Gastroenterologist, and Professor of Medicine and Consultant Cardiologist, College of Medicine, King Khalid University Hospital and King Saud University, Riyadh, Saudi Arabia.

View Article and Find Full Text PDF

In a simple uncontrolled toxicological study 27 workers of an anesthesiology-resuscitation department of a hospital type III were examined. Besides detailed clinical examination, determination of basic hematological and biochemical parameters as well as ultrasonography, also selected parameters of proteosynthetic function of the liver, some so-called proteins of the acute phase and the biological half-life of antipyrine were established in the workers under study. The occurrence of pathological findings in the picture of the examinations performed was related to long-term professional exposure to halothane over the period of one year before the examination.

View Article and Find Full Text PDF